Vienna Hypothermic Oxygenated Machine Perfusion Study
Recruiting now
Conditions studied: End Stage Liver Disease, Hepatocellular Carcinoma
In brief
In this observational cohort study data on all patients undergoing liver transplantation after hypothermic oxygenated machine perfusion at Medical University of Vienna will be prospectively recorded. Investigation of short- and long-term outcome in this cohort will be conducted.
Key facts
- Study ID
- NCT06418165
- Run by
- Medical University of Vienna
- People needed
- 500
- Starts
- 2018-01-01
- Expected to finish
- 2038-12-31
- Last updated by the study team
- 2024-05-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- patients undergoing liver transplantation with the use of hypothermic oxygenated machine perfusion
- age ≥ 18 years
You may not qualify if…
- pregnancy
- partial grafts
- the anatomical integrity of the liver is not preserved in a way that makes the perfusion of the liver possible
Where it is running
- Medical University of Vienna — Vienna, Austria (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.